Predictive Genetic Testing and Consumer Wellness Genomics Companies

Invitae acquires Genomic Health for $4 billion: This strategic move consolidates two major players in genetic testing, expanding Invitae's reach and offerings in cancer screening, hereditary risks, and other areas.

23andMe partners with Mayo Clinic: This collaboration will leverage 23andMe's large research database and Mayo Clinic's expertise in clinical research to develop new insights into the link between genetics and health outcomes.

Dante Labs merges with Nebula Genomics: This union combines Dante Labs' advanced sequencing technology with Nebula Genomics' comprehensive data analysis platform, aiming to democratize access to advanced genetic testing and interpretation.

Color Genomics introduces "MyGut Mind": This new test analyzes the gut microbiome's connection to cognitive and emotional health, providing personalized insights for optimizing mental well-being.

Helix launches "Express Ancestry": This rapid ancestry test delivers results in as little as two weeks, catering to the growing demand for quick and affordable ancestral insights.

Fulgent Genetics unveils "Expanded Carrier Screening 2.0": This expanded panel tests for over 300 carrier conditions, offering parents more comprehensive prenatal screening options.

• 23andMe, Inc. (California)


• Myriad Genetics, Inc. (US)


• Hoffmann-La Roche Ltd. (Switzerland)


• Abbott Laboratories (US)


• Genesis Genetics (US)


• Agilent Technologies (US)


• Thermo Fisher Scientific, Inc. (US)


• Bureau Gravimétrique International (China)


• Bio-Rad Laboratories Inc. (US)


• Illumina, Inc. (US)


• Counsyl, Inc. (California)


• ARUP Laboratories (US)